Skip to content

Clinical trials

Optic Nerve Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Optic Nerve Diseases Country / region: United States Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20111
20121
20153
20162
20182
20193
20202
20221
20231
20242
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed5
Terminated5
Unknown status2
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University3
MD Stem Cells2
Stanford University2
University of Miami2
Astellas Pharma Global Development, Inc.1
Bayer1
Children's National Research Institute1
Clene Nanomedicine1
Dompé Farmaceutici S.p.A1
Illinois Institute of Technology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Optic Nerve Diseases25
Glaucoma11
Retinal Diseases9
Optic Neuropathy, Ischemic6
Macular Degeneration5
Blindness3
Eye Diseases3
Optic Atrophy, Hereditary, Leber3
Vision Disorders3
Cone Dystrophy2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.